August 29, 2024FinancialNotice Concerning Secondary Offering of Shares in the International Markets (PDF 316.27 KB)
August 29, 2024Financial Notice Concerning Acquisition of Own Shares and Cancellation of Treasury Stock (PDF 134.55 KB) (Acquisition of the Company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan, and cancellation of treasury stock pursuant to the Article 178 of the Companies Act of Japan)
August 15, 2024CorporateTerumo Blood and Cell Technologies and Charles River Demonstrate Versatility of FINIA Automated Cell and Gene Therapy Fill and Finish PlatformNew publication confirms the ability of Terumo BCT’s FINIA™ Fill and Finish System to automate large volumes across multiple autologous and allogeneic cell and gene therapy workflows.